Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors.
(9AKL619)Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors.
(9AKL619)Custom deal tombstone celebrating the initial public offering by Rameda, Pharmaceuticals, a Cairo-based generic drug firm.
(9AMF339)Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.
(20ALJ071)Custom crystal marking construction of Our Medical Home North Lakes, located in Queensland’s Moreton Bay region. The facility is part of a network of medical centres operated by Australia’s Cornerstone Health.
(20AJH028)Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.
(20AMF085)Custom deal tombstone commemorating the acquisition of Van London, a Texas-based designer and manufacturer of high-quality sensors for the industrial, lab, and biotech markets.
(9AKL686)Custom deal toy marking a follow-on stock offering by Translate Bio. The biotech firm specializes in the treatment of diseases caused by protein or gene dysfunction.
(9ALJ491)